Drugs / Methotrexat
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04227366 Background | Nov 2019 → Mar 2021 | rheumatoid arthritis | Biocad | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Methotrexat | “Drug: Methotrexat” NCT04227366 ↗ |